CAPT ACTP 2012

2012 Annual Conference
May 6-8, 2012
Hyatt Regency Montreal
Montreal, Quebec

The 2012 CAPT Annual Conference “Effectiveness and safety of therapeutics: Dealing with transparency, minimizing bias, and improving knowledge translation to concerned stakeholders” was  held  from May 6-7, 2012, at the Hyatt Regency in Montreal, Quebec.

CAPT 2012 Scientific Program

We have been granted permission to post the following Invited speaker presentations:

Sunday, May 6, 2012

Pre-Conference Symposium
Introduction to Pharmacoepidemiology
Dr. Anais Lacasse

Issues Panel: Biomarkers and Surrogate Outcomes: Linking Relevance, Regulation, and Reimbursement in Canada
Clinical Trials and Clinical Practice: Surrogates at the Clinician/Patient Interface
Dr. Linda Lévesque

The Regulatory Perspective on Surrogates
Dr. Agnes Klein

The Impact of Surrogates in Reimbursement Recommandations
Mrs. Angela Rocchi
 

Monday, May 7, 2012

Engaging Patients and Citizens in HTA Decision Making
Perspective as a Decision Maker on the Involvement of Patients and Citizens in HTA Decison Making
Dr. Gerald Evans

 

Tuesday, May 8, 2012

Canada’s Drug Effectiveness and Safety Network
DSEN’s Experience
Dr. Diane Forbes

Pharmaceutical Experience
Dr. William Dempster

US Experience
Dr. Sean Hennessy

Lost Productivity and Indirect Costs
Work Related Lost Productivity: What is the Economic Impact in Canadians Suffering with Psoriasis?
Mr. Brian Chan

Financial Burden of Cancer on the Caregiver
Dr. Chris Longo

Hot Topic Session – Substainability of the Healthcare System, and Equitable and Timely Access to New Medications – Attainable Goals ?

Government perspective
Mrs. Lucie Robitaille

Industry perspective
Mr. Mark Fleming


CAPT JOURNAL

All abstracts accepted for presentation have been published on-line in the Journal of Population Therapeutics and Clinical Pharmacology at http://www.jptcp.com/. (J Popul Ther Clin Pharmacol Vol 19 (2):e113-e149; May 1, 2012).


CAPT STUDENT AWARDS

CAPT is pleased to announce that the following presentation awards were made at the conference:

The Best student podium award: This awards were for excellence in an oral presentation by a student. The winner, W. Alsabbach, University of Saskatchewan, received an award of $200.00.

The Best student poster award: This award was for excellence in a poster presentation by a student. The winner, C. Quianquian Wu, McGill University, received an award of $200.00.

CAPT STUDENT TRAVEL BURSARIES

20 full-time students were awarded travel bursaries to help offset travel and registration to the 2012 conference.

CAPT 2012 CONFERENCE PARTNERS

CAPT would like to especially thank the 24 partners that provided funding to make the 2012 annual conference possible:

Platinum
DSEN / CIHR
Janssen
Merck Canada Inc.
Sanofi-Aventis

Gold
Amgen Canada Inc.
Astellas Pharma Canada
CNODES/CIHR
GlaxoSmithKline Inc.
Novartis Pharmaceuticals
Pfizer Canada Inc.
Takeda Canada

Silver
Axia Research
Bayer Canada
Canada’s Research-Based Pharmaceutical Companies (Rx&D)
LA-SER
Optuminsight Life Sciences
Purdue Pharma
StatSciences
Union Chemique Belge (UCB)

Bronze
Cornerstone Research
Hope Research Centre
Institute of Health Economics
Oxford Outcomes
Servier Canada

CAPT 2012 SCIENTIFIC PLANNING COMMITTEE

Anick Bérard, University of Montreal (Chair)
Farah Jivraj, Sanofi-aventis Canada
Nicole Mittmann, HOPE Reseach Centre
Corine Mizrahi, CNODES
Wendy Morton, Merck Canada
Elham Rahme, McGill University
Angela Rocchi, Axia Research

CAPT 2012 LOCAL ORGANIZING COMMITTEE

Odile Sheehy (Chair), CHU Sainte-Justine
Allan Gillman, IMS Brogan

ANNOUNCEMENT
The evolving Federal and Provincial directives on COVID-19 will guide our decision in regard to the 2020 Conference, scheduled for October 26th and 27th.

More Info
X